Search
LENSAR Inc
LNSRAdd to Watchlist
5.540USD
-0.290-4.97%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
67.06MMarket Cap
2.27P/E TTM
More Details of LENSAR Inc Company
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
LENSAR Inc Info
Ticker SymbolLNSR
Company nameLENSAR Inc
IPO dateSep 21, 2020
CEOCurtis (Nicholas T)
Number of employees140
Security typeOrdinary Share
Fiscal year-endSep 21
Address2800 Discovery Drive
CityORLANDO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32826
Phone18885367271
Websitehttps://www.lensar.com/
Ticker SymbolLNSR
IPO dateSep 21, 2020
CEOCurtis (Nicholas T)
Company Executives of LENSAR Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
+7.35%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+8.36%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
+7.35%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+8.36%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
34.31M
66.43%
Europe
8.43M
16.31%
Asia (excluding South Korea)
8.02M
15.53%
South Korea
658.00K
1.27%
Other
238.00K
0.46%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
North Run Capital, LP
9.35%
Brandes Investment Partners, L.P.
7.07%
Curtis (Nicholas T)
7.06%
BlackRock Institutional Trust Company, N.A.
4.84%
Link (William J)
4.55%
Other
67.12%
Shareholders
Shareholders
Proportion
North Run Capital, LP
9.35%
Brandes Investment Partners, L.P.
7.07%
Curtis (Nicholas T)
7.06%
BlackRock Institutional Trust Company, N.A.
4.84%
Link (William J)
4.55%
Other
67.12%
Shareholder Types
Shareholders
Proportion
Investment Advisor
27.45%
Individual Investor
21.79%
Hedge Fund
11.93%
Investment Advisor/Hedge Fund
7.97%
Pension Fund
1.40%
Bank and Trust
1.34%
Research Firm
1.11%
Other
27.02%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
172
6.68M
55.41%
-342.76K
2025Q4
162
5.97M
49.99%
-603.16K
2025Q3
148
5.64M
47.18%
-98.25K
2025Q2
124
7.77M
65.87%
+342.80K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
North Run Capital, LP
1.10M
9.21%
--
--
Mar 23, 2025
Brandes Investment Partners, L.P.
856.22K
7.17%
+78.51K
+10.10%
Dec 31, 2025
Curtis (Nicholas T)
792.29K
6.63%
--
--
Oct 24, 2025
BlackRock Institutional Trust Company, N.A.
585.69K
4.9%
+10.13K
+1.76%
Dec 31, 2025
Link (William J)
543.27K
4.55%
-7.37K
-1.34%
Oct 24, 2025
Connaughton (Alan B.)
274.57K
2.3%
-2.39K
-0.86%
Feb 18, 2026
Lindstrom (Richard L)
239.04K
2%
-7.37K
-2.99%
Oct 24, 2025
Dimensional Fund Advisors, L.P.
224.93K
1.88%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
217.73K
1.82%
-156.00
-0.07%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
View more
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
iShares Micro-Cap ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
Franklin US Small Cap Multifactor Index ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
